Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
RPS.L Share News (RPS)
RPS Share
Price
RPS Share
News
RPS Share
Chat
RPS Share
Trades
RPS
Live RNS
RPS Share
Charts
RPS Broker
Ratings
RPS Directors
Deals
RPS Financial
Diary
RPS
Fundamentals
RPS Short
Positions
RPS
Media
RPS Company
Research
RPS Company
Timeline
- There is currently no data for RPS
Tuesday broker round-up
Pearson: Berenberg reiterates sell with a target price of 500p.
Gamesys Group: Berenberg reiterates buy with a target price of 1,700p.
Forterra: Canaccord reiterates buy with a target price of 272p.
Ideagen: Canaccord reiterates buy with a target price of 310p.
AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,000p.
GSK: Deutsche Bank reiterates sell with a target price of 1,150p.
Avast: Goldman Sachs reiterates buy with a target price of 600p.
Keller Group: Liberum reiterates buy with a target price of 1,070p.
RPS Group: Liberum reiterates buy with a target price of 100p.
Cairn Energy: Peel Hunt reiterates add with a target price of 225p.
DFS Furniture: Peel Hunt reiterates buy with a target price of 320p.
Travis Perkins: JP Morgan reiterates neutral with a target price of 1,460p.
Clarkson: JP Morgan reiterates neutral with a target price of 2,756p.
RHI Magnesita: Barclays reiterates overweight with a target price of 3,400p.
S4 Capital: Barclays initiates at equal weight with a target price of 475p.
Network International: Jefferies reiterates hold with a target price of 410p.
Latest RPS News
- LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy
12 Aug 2021 - RPS Group swings to interim profit and reinstates "modest" dividend
11 Aug 2021 - LONDON BROKER RATINGS: Liberum raises IAG; Berenberg downgrades M&G
11 Aug 2021 - UK earnings, trading statements calendar - next 7 days
4 Aug 2021 - RPS Group makes progress in renewables by winning UK water pacts
15 Jul 2021 - RPS to consider investor views after pay rebellion
29 Jun 2021 - RPS sits down with shareholders to clarify former finance director pay
29 Jun 2021 - RPS says performance in line with expectations despite revenue drop
28 Apr 2021
Related News
'It's still working': More are living with cancer as era of targeted drugs takes hold
* Targeted therapies drive rising cancer survival rates, experts say
AstraZeneca breast cancer drug camizestrant shows "sustained" benefit
(Alliance News) - AstraZeneca PLC on Tuesday reported encouraging test results for its breast cancer treatment camizestrant.
BSF Enterprise shares jump on paper in praise of "T-rex leather"
(Alliance News) - BSF Enterprise on Tuesday saw its shares rise after the publication of a paper on one of its subsidiaries' synthetic leather product...
RPS.L News
LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy
LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy
RPS Group swings to interim profit and reinstates "modest" dividend
RPS Group swings to interim profit and reinstates "modest" dividend
LONDON BROKER RATINGS: Liberum raises IAG; Berenberg downgrades M&G
LONDON BROKER RATINGS: Liberum raises IAG; Berenberg downgrades M&G
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
RPS Group makes progress in renewables by winning UK water pacts
RPS Group makes progress in renewables by winning UK water pacts
RPS to consider investor views after pay rebellion
(Sharecast News) - RPS said it would take shareholder views into account after consulting investors over a pay deal for departing chief financial offi...
RPS sits down with shareholders to clarify former finance director pay
RPS sits down with shareholders to clarify former finance director pay
RPS says performance in line with expectations despite revenue drop
RPS says performance in line with expectations despite revenue drop
Follow the stocks
